The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.89BBRL
562.54M · vs all stocks (USD)
Updated Aug 21, 2026
Revenue (TTM)
31.85BBRL
6.19B · vs all stocks (USD)
Updated Aug 21, 2026
Profit Margin
-1.35%
Updated Aug 21, 2026
Beta
0.2560x
vs all stocks
Updated Aug 21, 2026
52-Week Change
-82.93%
vs all stocks
Updated Aug 21, 2026
Market Capitalization
2.89BBRL
562.54M · vs all stocks (USD)
Updated Aug 21, 2026
Enterprise Value
12.44BBRL
2.42B · vs all stocks (USD)
Updated Aug 21, 2026
Forward P/E
4.15x
Updated Aug 21, 2026
Price to Sales (TTM)
0.0998x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 0.09×.Updated Aug 21, 2026
Price to Book (MRQ)
0.0658x
Updated Aug 21, 2026
Enterprise to Revenue
0.3910x
Updated Aug 21, 2026
Enterprise to EBITDA
5.25x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 2.72×.Updated Aug 21, 2026
Gross Margin
15.22%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 11.52%.Updated Aug 21, 2026
Profit Margin
-1.35%
Updated Aug 21, 2026
Operating Margin
6.62%
Updated Aug 21, 2026
Return on Assets (TTM)
1.21%
Updated Aug 21, 2026
Return on Equity (TTM)
-0.89%
Updated Aug 21, 2026
Revenue (TTM)
31.85BBRL
6.19B · vs all stocks (USD)
Updated Aug 21, 2026
Revenue per Share (TTM)
64.10BRLUpdated Aug 21, 2026
Quarterly Revenue Growth
3.50%
Updated Aug 21, 2026
Gross Profit (TTM)
3.67BBRL
713.63M · vs all stocks (USD)
Updated Aug 21, 2026
EBITDA (TTM)
4.58BBRL
890.17M · vs all stocks (USD)
Updated Aug 21, 2026
Net Income (TTM)
-428.85MBRL
-83.38M · vs all stocks (USD)
Updated Aug 21, 2026
Quarterly Earnings Growth (YoY)
3.48%
Updated Aug 21, 2026
Operating Cash Flow (TTM)
1.80BBRL
350.87M · vs all stocks (USD)
Updated Aug 21, 2026
Levered Free Cash Flow (TTM)
-512.57MBRL
-99.66M · vs all stocks (USD)
Updated Aug 21, 2026
Payout Ratio
0.00%
Updated Aug 21, 2026
Minority Interest (Equity)
1.72MBRLFY2025 · Dec 31, 2025
Revenue
31.58BBRLFY2025 · Dec 31, 2025
Cost of Goods Sold
27.85BBRLFY2025 · Dec 31, 2025
Gross Profit
3.72BBRLFY2025 · Dec 31, 2025
Operating Income
1.91BBRL
370.98M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-233.84MBRLFY2025 · Dec 31, 2025
Income Tax Expense
-91.67MBRLFY2025 · Dec 31, 2025
Net Income
-142.17MBRLFY2025 · Dec 31, 2025
EBIT
2.48BBRLFY2025 · Dec 31, 2025
EBITDA (Income Statement)
4.61BBRLFY2025 · Dec 31, 2025
Selling, General & Administrative
259.31MBRLFY2025 · Dec 31, 2025
Other Operating Expenses
513.39MBRLFY2025 · Dec 31, 2025
Non-operating Interest Income
527.18MBRLFY2025 · Dec 31, 2025
Non-operating Interest Expense
2.72BBRLFY2025 · Dec 31, 2025
EPS (Basic)
-0.2800BRLFY2025 · Dec 31, 2025
EPS (Diluted)
-0.2800BRLFY2025 · Dec 31, 2025
Basic Shares Outstanding
501.78MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
501.78MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-142.17MBRLFY2025 · Dec 31, 2025
Minority Interests (P&L)
422.00KBRLFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00BRLFY2025 · Dec 31, 2025
Operating Cash Flow
2.54BBRLFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
875.44MBRLFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-142.17MBRLFY2025 · Dec 31, 2025
Stock-based Compensation
22.85MBRLFY2025 · Dec 31, 2025
Other Non-cash Items
2.24BBRLFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
318.95MBRLFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
97.83MBRLFY2025 · Dec 31, 2025
Net Intangibles (CF)
0.00BRLFY2025 · Dec 31, 2025
Purchase of Investments
-13.23BBRLFY2025 · Dec 31, 2025
Sale of Investments
15.74BBRLFY2025 · Dec 31, 2025
Other Investing Activity
-1.06BBRLFY2025 · Dec 31, 2025
Net Investing Cash Flow
1.46BBRLFY2025 · Dec 31, 2025
Long-term Debt Issuance
5.21BBRLFY2025 · Dec 31, 2025
Long-term Debt Payments
-5.21BBRLFY2025 · Dec 31, 2025
Common Stock Repurchase
-386.37MBRLFY2025 · Dec 31, 2025
Other Financing Charges
-500.48MBRLFY2025 · Dec 31, 2025
Net Financing Cash Flow
-916.31MBRLFY2025 · Dec 31, 2025
Shares Outstanding
475.06MSharesUpdated Aug 21, 2026
Float Shares
233.10MSharesUpdated Aug 21, 2026
% Held by Insiders
39.78%
vs all stocks
Updated Aug 21, 2026
% Held by Institutions
54.24%
vs all stocks
Updated Aug 21, 2026
Total Cash (MRQ)
8.33BBRL
1.62B · vs all stocks (USD)
Updated Aug 21, 2026
Total Cash per Share (MRQ)
17.54BRLUpdated Aug 21, 2026
Total Debt (MRQ)
16.22BBRL
3.15B · vs all stocks (USD)
Updated Aug 21, 2026
Total Debt to Equity (MRQ)
0.3367x
Updated Aug 21, 2026
Current Ratio (MRQ)
1.79x
Updated Aug 21, 2026
Book Value per Share (MRQ)
101.64BRLUpdated Aug 21, 2026
Total Assets
72.29BBRL
14.06B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
10.54BBRLFY2025 · Dec 31, 2025
Total Liabilities
24.04BBRLFY2025 · Dec 31, 2025
Total Non-current Assets
61.75BBRLFY2025 · Dec 31, 2025
Total Non-current Liabilities
18.49BBRLFY2025 · Dec 31, 2025
Total Current Liabilities
5.55BBRLFY2025 · Dec 31, 2025
Cash & Cash Equivalents
875.44MBRLFY2025 · Dec 31, 2025
Other Short-term Investments
6.99BBRLFY2025 · Dec 31, 2025
Accounts Receivable
346.16MBRLFY2025 · Dec 31, 2025
Inventory
362.80MBRLFY2025 · Dec 31, 2025
Accounts Payable
360.30MBRLFY2025 · Dec 31, 2025
Short-term Debt
1.41BBRLFY2025 · Dec 31, 2025
Long-term Debt
14.04BBRLFY2025 · Dec 31, 2025
Common Stock (Book)
38.87BBRLFY2025 · Dec 31, 2025
Total Shareholders' Equity
48.25BBRL
9.38B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
961.42MBRLFY2025 · Dec 31, 2025
52-Week Low
6.01BRLUpdated Aug 21, 2026
52-Week High
42.66BRLUpdated Aug 21, 2026
52-Week Change
-82.93%
vs all stocks
Updated Aug 21, 2026
Beta
0.2560x
vs all stocks
Updated Aug 21, 2026
50-Day MA
10.39BRLUpdated Aug 21, 2026
200-Day MA
12.17BRLUpdated Aug 21, 2026
Avg 10-Day Volume
12.97MSharesUpdated Aug 21, 2026
Avg 30-Day Volume
7.37MSharesUpdated Aug 21, 2026
Diluted EPS (TTM)
-0.3600BRLUpdated Aug 21, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
Three Turnover Ratios Elevated
Collects fast, clears inventory fast, and pays suppliers fast too.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Upstream position: supplies 5 industries, depends on 3Notable
Outgoing: 5.00Incoming: 3.00
Scale
Revenue is $6.19B, above the global median of $520.53MNotable
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedOperating Income Growing With Multi-Year Revenue GrowthThree Turnover Ratios Elevated
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedOperating Income Growing With Multi-Year Revenue GrowthThree Turnover Ratios Elevated
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility ElevatedOperating Income Growing With Multi-Year Revenue GrowthThree Turnover Ratios Elevated